Literature DB >> 12639243

Human immunodeficiency virus type 1 subtype and other factors associated with extrapulmonary Cryptococcosis among patients in Thailand with AIDS.

Pauli N Amornkul1, Dale J Hu, Somsit Tansuphasawadikul, Sherline Lee, Boonchuey Eampokalap, Sirirat Likanonsakul, Robert Nelson, Nancy L Young, Rana A Hajjeh, Khanchit Limpakarnjanarat, Timothy D Mastro.   

Abstract

Delineating factors associated with extrapulmonary cryptococcosis (EPC), a major disease burden among Thailand's AIDS patients, can clarify its pathogenesis and guide preventive interventions. From November 1993 through June 1996, enhanced surveillance of 2261 human immunodeficiency virus (HIV)-seropositive patients in a hospital near Bangkok showed EPC among 561 of 1553 AIDS patients (36.1%). Univariate analysis results were confirmed by multivariate analyses of data on 1259 patients. Logistic regression models identified factors significantly associated with EPC to be male sex (adjusted odds ratio [aOR], 2.0; 95% confidence interval [CI], 1.3-2.9), age <33 years (aOR, 1.5; 95% CI, 1.2-1.9), severe immunosuppression (aOR, 1.8; 95% CI, 1.3-2.6), not injecting drugs (aOR, 3.0; 95% CI, 1.7-5.5), and infection with HIV-1 circulating from CRF01_AE (formerly subtype E) versus subtype B (aOR, 2.3; 95% CI, 1.2-4.5). The association with CRF01_AE may result from undetermined markers of exposure or viral subtype effects on host immune responses. Better understanding of the epidemiology of EPC may reduce EPC incidence through targeted primary prevention and treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12639243     DOI: 10.1089/088922203762688586

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Analyses of pediatric isolates of Cryptococcus neoformans from South Africa.

Authors:  Kathleen J Miglia; Nelesh P Govender; Jenny Rossouw; Susan Meiring; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.

Authors:  Romain Micol; Ayden Tajahmady; Olivier Lortholary; Suna Balkan; Catherine Quillet; Jean-Philippe Dousset; Hak Chanroeun; Yoann Madec; Arnaud Fontanet; Yazdan Yazdanpanah
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

3.  Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature.

Authors:  Eric D Chow; Oliver W Liu; Sean O'Brien; Hiten D Madhani
Journal:  Curr Genet       Date:  2007-07-28       Impact factor: 3.886

4.  CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain.

Authors:  Xiaolong He; Xiaolu Shi; Santhosh Puthiyakunnon; Like Zhang; Qing Zeng; Yan Li; Swapna Boddu; Jiawen Qiu; Zhihao Lai; Chao Ma; Yulong Xie; Min Long; Lei Du; Sheng-He Huang; Hong Cao
Journal:  J Biomed Sci       Date:  2016-02-20       Impact factor: 8.410

Review 5.  An Overview of Sex Bias in C. neoformans Infections.

Authors:  Tiffany E Guess; Joseph A Rosen; Erin E McClelland
Journal:  J Fungi (Basel)       Date:  2018-04-18

Review 6.  The X chromosome and sex-specific effects in infectious disease susceptibility.

Authors:  Haiko Schurz; Muneeb Salie; Gerard Tromp; Eileen G Hoal; Craig J Kinnear; Marlo Möller
Journal:  Hum Genomics       Date:  2019-01-08       Impact factor: 4.639

7.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

8.  Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.

Authors:  Emilio Letang; Matthias C Müller; Alex J Ntamatungiro; Namvua Kimera; Diana Faini; Hansjakob Furrer; Manuel Battegay; Marcel Tanner; Christoph Hatz; David R Boulware; Tracy R Glass
Journal:  Open Forum Infect Dis       Date:  2015-04-02       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.